254 related articles for article (PubMed ID: 34543097)
1. Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli.
Mühlen S; Zapol'skii VA; Bilitewski U; Dersch P
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0095821. PubMed ID: 34543097
[TBL] [Abstract][Full Text] [Related]
2. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
mBio; 2012; 3(5):. PubMed ID: 23033475
[TBL] [Abstract][Full Text] [Related]
3. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
[TBL] [Abstract][Full Text] [Related]
4. Control of Type III Secretion System Effector/Chaperone Ratio Fosters Pathogen Adaptation to Host-Adherent Lifestyle.
Elbaz N; Socol Y; Katsowich N; Rosenshine I
mBio; 2019 Sep; 10(5):. PubMed ID: 31530678
[TBL] [Abstract][Full Text] [Related]
5. SepD/SepL-dependent secretion signals of the type III secretion system translocator proteins in enteropathogenic Escherichia coli.
Deng W; Yu HB; Li Y; Finlay BB
J Bacteriol; 2015 Apr; 197(7):1263-75. PubMed ID: 25645555
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
Serapio-Palacios A; Finlay BB
Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
[TBL] [Abstract][Full Text] [Related]
7. Assay for Type III Secretion in Escherichia coli.
Mitrovic B; Sal-Man N
Methods Mol Biol; 2022; 2427():37-46. PubMed ID: 35619023
[TBL] [Abstract][Full Text] [Related]
8. The Bordetella Secreted Regulator BspR Is Translocated into the Nucleus of Host Cells via Its N-Terminal Moiety: Evaluation of Bacterial Effector Translocation by the Escherichia coli Type III Secretion System.
Abe A; Nishimura R; Tanaka N; Kurushima J; Kuwae A
PLoS One; 2015; 10(8):e0135140. PubMed ID: 26247360
[TBL] [Abstract][Full Text] [Related]
9. Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.
Soto E; Espinosa N; Díaz-Guerrero M; Gaytán MO; Puente JL; González-Pedrajo B
J Bacteriol; 2017 Jan; 199(1):. PubMed ID: 27795324
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Type III Secretion System of Enteropathogenic Escherichia coli Leads to Remodeling of Its Membrane Composition and Function.
Zacharia A; Pal RR; Katsowich N; Mannully CT; Ibrahim A; Alfandary S; Serruya R; Baidya AK; Ben-Yehuda S; Rosenshine I; Moussaieff A
mSystems; 2022 Jun; 7(3):e0020222. PubMed ID: 35477304
[TBL] [Abstract][Full Text] [Related]
11. The Type III Secretion System of Pathogenic Escherichia coli.
Slater SL; Sågfors AM; Pollard DJ; Ruano-Gallego D; Frankel G
Curr Top Microbiol Immunol; 2018; 416():51-72. PubMed ID: 30088147
[TBL] [Abstract][Full Text] [Related]
12. Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated.
DeVinney R; Stein M; Reinscheid D; Abe A; Ruschkowski S; Finlay BB
Infect Immun; 1999 May; 67(5):2389-98. PubMed ID: 10225900
[TBL] [Abstract][Full Text] [Related]
13. Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli.
Cameron EA; Curtis MM; Kumar A; Dunny GM; Sperandio V
mBio; 2018 Dec; 9(6):. PubMed ID: 30514785
[TBL] [Abstract][Full Text] [Related]
14. Role of EscU auto-cleavage in promoting type III effector translocation into host cells by enteropathogenic Escherichia coli.
Thomassin JL; He X; Thomas NA
BMC Microbiol; 2011 Sep; 11():205. PubMed ID: 21933418
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM structure of the EspA filament from enteropathogenic Escherichia coli: Revealing the mechanism of effector translocation in the T3SS.
Lyons BJE; Atkinson CE; Deng W; Serapio-Palacios A; Finlay BB; Strynadka NCJ
Structure; 2021 May; 29(5):479-487.e4. PubMed ID: 33453150
[TBL] [Abstract][Full Text] [Related]
16. Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector.
Nieto-Pelegrin E; Kenny B; Martinez-Quiles N
Cell Adh Migr; 2014; 8(4):404-17. PubMed ID: 25482634
[TBL] [Abstract][Full Text] [Related]
17. Type Three Secretion System in Attaching and Effacing Pathogens.
Gaytán MO; Martínez-Santos VI; Soto E; González-Pedrajo B
Front Cell Infect Microbiol; 2016; 6():129. PubMed ID: 27818950
[TBL] [Abstract][Full Text] [Related]
18. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
[TBL] [Abstract][Full Text] [Related]
19. Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.
Arbeloa A; Oates CV; Marchès O; Hartland EL; Frankel G
Infect Immun; 2011 Mar; 79(3):1067-76. PubMed ID: 21189318
[TBL] [Abstract][Full Text] [Related]
20. Esp-independent functional integration of the translocated intimin receptor (Tir) of enteropathogenic Escherichia coli (EPEC) into host cell membranes.
Michgehl S; Heusipp G; Greune L; Rüter C; Schmidt MA
Cell Microbiol; 2006 Apr; 8(4):625-33. PubMed ID: 16548888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
